We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christopher Granger MD, FACC, FAHA

Christopher B Granger MD, FACC, FAHA

Professor of Medicine, Division of Cardiology, Department of Medicine, Duke University Medical Center; Director, Cardiac Care Unit, Duke University Medical Center

Dr. Christopher Granger is a Professor of Medicine in the Division of Cardiology at Duke University and Director of the Cardiac Care Unit for the Duke University Medical Center.  Dr. Granger is a Fellow of the American College of Cardiology, the American Heart Association, and of the European Society of Cardiology.  He is Associate Editor of the American Heart Journal and serves on the editorial board of the Journal of the American College of Cardiology.  He is a cardiology section author for Current Medical Diagnosis and Treatment. He serves on the publication oversight committee of the American Heart Association and he is chairman of the Advisory Working Group of the American Heart Association Mission: Lifeline program.  He is a member of the 2011 ACC/AHA STEMI Guidelines Committee. He has served on FDA advisory committees on an ad hoc basis.  He is on the Board of External Experts of the National Heart, Lung and Blood Institute (NHLBI). 

Dr. Granger’s primary research interest is in the conduct and methodology of large randomized clinical trials in heart disease; he has co-authored more than 400 peer-reviewed manuscripts. He currently serves on a number of clinical trial steering committees and data safety monitoring committees.  He has coordinated the Duke Clinical Research Institutes' activities in many clinical trials evaluating acute MI reperfusion and antithrombotic strategies in acute coronary syndromes and in atrial fibrillation.

Dr. Granger is co-chairman of the Steering Committee of the ARISTOTLE trial assessing an oral factor Xa inhibitor for stroke prevention in atrial fibrillation. In addition, he is co-director of the Reperfusion of Acute MI in Carolina Emergency Departments (RACE) projects, North Carolina state-wide programs to improve reperfusion care for acute myocardial infarction and care for cardiac arrest.